Cargando…

From a decentralized clinical trial to a decentralized and clinical-trial-in-a-box platform: Towards patient-centric and equitable trials

BACKGROUND/OBJECTIVE: Despite the intuitive attractiveness of bringing research to participants rather than making them come to central study sites, widespread decentralized enrollment has not been common in clinical trials. METHODS: The need for clinical research in the context of the COVID-19 pand...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dulko, Dorothy, Kwong, Manlik, Palm, Marisha E., Trinquart, Ludovic, Selker, Harry P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cambridge University Press 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10663768/ https://www.ncbi.nlm.nih.gov/pubmed/38028335 http://dx.doi.org/10.1017/cts.2023.629

Ejemplares similares

The use of N-of-1 trials to generate real-world evidence for optimal treatment of individuals and populations
por: Selker, Harry P., et al.
Publicado: (2023)

Decentralized clinical trials in the trial innovation network: Value, strategies, and lessons learned
por: Hanley, Daniel F., et al.
Publicado: (2023)

Leveraging patient‐centric sampling for clinical drug development and decentralized clinical trials: Promise to reality
por: Maass, Katie F., et al.
Publicado: (2022)

191 Ethical Considerations of Decentralized Clinical Trials
por: Pascalev, Assya
Publicado: (2022)

Assessing the Financial Value of Decentralized Clinical Trials
por: DiMasi, Joseph A., et al.
Publicado: (2022)

Decentralized Clinical Trials: The Future of Medical Product Development?∗
por: Van Norman, Gail A.
Publicado: (2021)

Decentralized clinical trials (DCTs): A few ethical considerations
por: Petrini, Carlo, et al.
Publicado: (2022)

Sharing data among clinical trials of therapeutics in COVID-19: Barriers and facilitators to collaborating in a crisis
por: Palm, Marisha E., et al.
Publicado: (2021)

Opportunities and Challenges for Decentralized Clinical Trials: European Regulators’ Perspective
por: de Jong, Amos J., et al.
Publicado: (2022)

CRAFT—A Proposed Framework for Decentralized Clinical Trials Participation in Canada
por: Sundquist, Stephen, et al.
Publicado: (2021)

Opportunities and counterintuitive challenges for decentralized clinical trials to broaden participant inclusion
por: Goodson, Noah, et al.
Publicado: (2022)

76 Methods and Perceptions of Success for Patient Recruitment in Decentralized Clinical Trials
por: Tafuto, Barbara, et al.
Publicado: (2023)

Applying Systems Thinking to Inform Decentralized Clinical Trial Planning and Deployment
por: Betcheva, Lidia, et al.
Publicado: (2023)

Efficacy of Niclosamide vs Placebo in SARS-CoV-2 Respiratory Viral Clearance, Viral Shedding, and Duration of Symptoms Among Patients With Mild to Moderate COVID-19: A Phase 2 Randomized Clinical Trial
por: Cairns, Dana M., et al.
Publicado: (2022)

MediLinker: a blockchain-based decentralized health information management platform for patient-centric healthcare
por: Bautista, John Robert, et al.
Publicado: (2023)

Remote and semi-automated methods to conduct a decentralized randomized clinical trial
por: Cafaro, Teresa, et al.
Publicado: (2023)

Platform Architecture for Decentralized Positioning Systems
por: Kasmi, Zakaria, et al.
Publicado: (2017)

Feasibility study for a fully decentralized clinical trial in participants with functional constipation symptoms
por: Huh, Ki Young, et al.
Publicado: (2023)

Participant and research team perspectives on the conduct of a remote therapeutic COVID-19 clinical trial: A mixed methods approach
por: Daudelin, Denise H., et al.
Publicado: (2022)

eP187: Decentralization of clinical trials in the era of COVID-19: Implications for rare disease trials
por: Manjrekar, Kriti, et al.
Publicado: (2022)

Evaluation of a blockchain‐based dynamic consent platform (METORY) in a decentralized and multicenter clinical trial using virtual drugs
por: Huh, Ki Young, et al.
Publicado: (2022)

First experience of a fully decentralized clinical trial: The dawn of a new era in oncology
por: Taniguchi, Hiroya, et al.
Publicado: (2023)

Impact of Using A Mixed Data Collection Modality on Statistical Inferences in Decentralized Clinical Trials
por: Curtis, Alexandra, et al.
Publicado: (2022)

Internet Versus Noninternet Participation in a Decentralized Clinical Trial: Lessons From the ADAPTABLE Study
por: Shen, Rebecca, et al.
Publicado: (2023)

Towards a conceptual framework for addressing state-level barriers to decentralized clinical trials in the U.S.
por: Zawada, Stephanie J., et al.
Publicado: (2023)

DeTi: A Decentralized Ticketing Management Platform
por: Rafati Niya, Sina, et al.
Publicado: (2022)

Empowering clinical research in a decentralized world
por: De Brouwer, Walter, et al.
Publicado: (2021)

Legal, Regulatory, and Practical Issues to Consider When Adopting Decentralized Clinical Trials: Recommendations From the Clinical Trials Transformation Initiative
por: Apostolaros, Maria, et al.
Publicado: (2019)

Digital health technologies and Alzheimer’s disease clinical trials: might decentralized clinical trials increase participation by people with cognitive impairment?
por: Leroy, Victoire, et al.
Publicado: (2023)

New Opportunities and Cautionary Insights about Decentralizing and Deglobalizing Clinical Trials During the Great Lockdown
por: Dunlap, Denise, et al.
Publicado: (2020)

Application of Internet of Medical/Health Things to Decentralized Clinical Trials: Development Status and Regulatory Considerations
por: Sato, Takahiro, et al.
Publicado: (2022)

Role of decentralized clinical trials in cancer drug development: Results from a survey of oncologists and patients
por: de las Heras, Begoña, et al.
Publicado: (2022)

Association of Remote Technology Use and Other Decentralization Tools With Patient Likelihood to Enroll in Cancer Clinical Trials
por: Adams, Devon V., et al.
Publicado: (2022)

SSH-DAuth: secret sharing based decentralized OAuth using decentralized identifier
por: Krishna, Danda Prudhvi, et al.
Publicado: (2023)

The politics of decentralization : forests, power, and people /
Publicado: (2005)

ACTIV-6: Operationalizing a decentralized, outpatient randomized platform trial to evaluate efficacy of repurposed medicines for COVID-19
Publicado: (2023)

Secure Decentralized IoT Service Platform Using Consortium Blockchain
por: Zhang, Ruipeng, et al.
Publicado: (2022)

Swarm Learning for decentralized and confidential clinical machine learning
por: Warnat-Herresthal, Stefanie, et al.
Publicado: (2021)

LB1528C. Ivermectin for Treatment of Mild-to-Moderate COVID-19 in the Outpatient Setting A Decentralized, Placebo-controlled, Randomized, Platform Clinical Trial
por: Naggie, Susanna
Publicado: (2022)

Despite negative perceptions of clinical trial conduct during the coronavirus disease 2019 (COVID-19) pandemic, are decentralized clinical trial methods here to stay?
por: Cooper, Lisa, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ei7tavjvboo0jkom0i8e6a8krp